Alector (ALEC) FCF Margin Growth (3y) (2021 - 2026)
Powered by 
Analysis
Alector (ALEC) FCF Margin Growth (3y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | -2,024.00 |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | 1,067.00 |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | -1,272.00 |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | -2,228.00 |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | - |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | -5,426.00 |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | 4,612.00 |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | -203.00 |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | 14,060.00 |
| 10 | Alector | 274.68 Mn | 101.88 Mn | - | -95,290.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -95,290.00 |
| Mar 31, 2026 | -447,397.00 |
| Dec 31, 2025 | -32,433.00 |
| Sep 30, 2025 | -65,443.00 |
| Jun 30, 2025 | -55,014.00 |
| Mar 31, 2025 | -220,410.00 |
| Dec 31, 2024 | 25,425.00 |
| Sep 30, 2024 | -57,555.00 |
| Jun 30, 2024 | 27,221.00 |
| Mar 31, 2024 | 91,576.00 |
| Dec 31, 2023 | 69,344.00 |
| Sep 30, 2023 | 18,797.00 |
| Jun 30, 2023 | 137,998.00 |
| Mar 31, 2023 | 20,078.00 |
| Dec 31, 2022 | 16,246.00 |
| Sep 30, 2022 | 81,269.00 |
| Jun 30, 2022 | 23,303.00 |
| Mar 31, 2022 | 111,743.00 |
| Dec 31, 2021 | -9,757.00 |
| Sep 30, 2021 | 58,972.00 |